Prokidney (PROK) Total Liabilities (2021 - 2026)
Prokidney's (PROK) quarterly Total Liabilities came in at $26.2 million in Q2 2026, down 19.9% year-over-year from $32.7 million in Q2 2025, and down 11.8% quarter-over-quarter from $29.7 million in Q1 2026.
Analysis
Prokidney (PROK) Total Liabilities (2021 - 2026) Analysis & Trends
Prokidney (PROK) has reported Total Liabilities for 6 consecutive years, with $26.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Liabilities fell 19.9% year-over-year to $26.2 million in Q2 2026; TTM through Jun 2026 was $26.2 million, a 19.9% decrease from a year earlier, with the FY2025 full-year figure at $34.8 million, down 11.8% from the prior year.
- Total Liabilities was $26.2 million for Q2 2026 at Prokidney, down from $29.7 million in the prior quarter.
- Over five years, Total Liabilities peaked at $39.4 million in Q4 2024 and troughed at $11.9 million in Q3 2022.
- A 5-year average of $25.7 million and a median of $27.0 million in 2023 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities jumped 66264.83% in 2022 and dropped 19.9% in 2026, its largest moves.
- Over 5 years, Total Liabilities stood at $13.1 million in 2022, then surged by 123.76% to $29.2 million in 2023, then soared by 34.98% to $39.4 million in 2024, then dropped by 11.8% to $34.8 million in 2025, then decreased by 24.73% to $26.2 million in 2026.
- The last three Total Liabilities figures came in at $26.2 million (Q2 2026), $29.7 million (Q1 2026), and $34.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 141.52 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 904.22 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 179.49 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 521.30 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 661.05 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 318.91 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 126.72 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 1.66 Bn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 132.83 Mn |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - | 26.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.18 Mn |
| Mar 31, 2026 | 29.68 Mn |
| Dec 31, 2025 | 34.78 Mn |
| Sep 30, 2025 | 33.27 Mn |
| Jun 30, 2025 | 32.68 Mn |
| Mar 31, 2025 | 36.08 Mn |
| Dec 31, 2024 | 39.44 Mn |
| Sep 30, 2024 | 31.33 Mn |
| Jun 30, 2024 | 26.80 Mn |
| Mar 31, 2024 | 24.73 Mn |
| Dec 31, 2023 | 29.22 Mn |
| Sep 30, 2023 | 23.62 Mn |
| Jun 30, 2023 | 27.28 Mn |
| Mar 31, 2023 | 14.17 Mn |
| Dec 31, 2022 | 13.06 Mn |
| Sep 30, 2022 | 11.87 Mn |
| Jun 30, 2022 | 15.63 Mn |
| Mar 31, 2022 | 13.11 Mn |
| Dec 31, 2021 | 13.38 Mn |
| Sep 30, 2021 | 7.76 Mn |